Analysed ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) News Sources
Zentalis Pharmaceuticals Announces Abstract Acceptance at ASCO 2026 Featuring Azenosertib in Combination with Paclitaxel for Platinum-Resistant Ovarian Cancer
21-04-2026
yahoo.com
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01-05-2026
yahoo.com
Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer
05-05-2026
yahoo.com
Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress
12-05-2026
yahoo.com
Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026
21-05-2026
yahoo.com
Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of Commercial Strategy
27-05-2026
yahoo.com
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01-06-2026
yahoo.com
Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026
17-07-2026
yahoo.com
What is the current price of ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ)?
The current price of ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) is $4.62.
ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) absolute price change since previous trading day?
The absolute price change of ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) since the previous trading day is $0.11.
ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) percentage price change since previous trading day?
The percentage price change of ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) since the previous trading day is 2.439%.
What is the most recent average sentiment score for ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ)?
The most recent average sentiment score for ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ)?
The most recent sentiment for ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ) is .
SEC-8K** Filing Available For ZENTALIS PHARMACEUTICALS INC (ZNTL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.